Cargando…
Repurposing Statins for Renal Protection: Is It a Class Effect?
Autores principales: | McWilliam, Stephen J., Antoine, Daniel J., Pirmohamed, Munir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867006/ https://www.ncbi.nlm.nih.gov/pubmed/29139191 http://dx.doi.org/10.1111/cts.12521 |
Ejemplares similares
-
Aminoglycoside-induced nephrotoxicity in children
por: McWilliam, Stephen J, et al.
Publicado: (2016) -
Urinary Biomarkers of Aminoglycoside-Induced Nephrotoxicity in Cystic Fibrosis: Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin
por: McWilliam, Stephen J., et al.
Publicado: (2018) -
Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
por: Mihalopoulos, Meredith, et al.
Publicado: (2020) -
Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020) -
Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
por: Turner, Richard Myles, et al.
Publicado: (2019)